Company Overview and News
The United States and China have agreed to “substantially” lessen trade deficit following two days of negotiations. China promised to “significantly” purchase U.S. goods and services that soothed investors’ nerves to a fair extent.
U.S. tech companies can finally breathe easy, at least for the time being. U.S. Treasury Secretary Steve Mnuchin on Sunday said that the U.S.-China trade conflict has been put on hold.
The S&P 500 Index ended a fairly quiet week nearly unchanged last week. With a fundamentally strong earnings season wrapping up, several businesses delivered additional good news in the form of payout raises.
U.S. tech companies can finally breathe easy, at least for the time being. U.S. Treasury Secretary Steve Mnuchin on Sunday said that the U.S.-China trade conflict has been put on hold. This certainly is good news for U.S. tech companies, particularly chipmakers, which have been reeling under pressure since the two countries sparked fears of a trade war by imposing tariffs and counter tariffs on imports from the two countries.
In value analysis, though price to earnings (P/E) and price to sales (P/S) are most preferred by investors, the underrated price-to-book ratio (P/B ratio) is also an easy-to-use valuation tool for identifying low-priced stocks with exceptional returns. The ratio is used to compare a stock’s market value/price to its book value.
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 05/15/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q4 2017.
In January of 2013 we used the Semi Equipment segment to project a firm broad Semi cycle and later, economic cycle.
FREMONT, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Lam Research Corporation (Nasdaq:LRCX) today announced its upcoming investor conference schedule:
Applied Materials Inc. led semiconductor-related stocks lower Friday as the chipmaker materials supplier’s outlook indicated a possible slowing in the recently hot sector.
The world’s largest semiconductor manufacturing equipment provider, Applied Materials (AMAT), reported record second fiscal quarter earnings yesterday. But the stock fell ~2% and another 4.5% in after-hours trading as the company reported weaker guidance for the third fiscal quarter. Its guidance was weaker than that of rivals KLA-Tencor (KLAC) and Lam Research (LRCX). LRCX and KLAC fell 1.73% and 0.
The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Lam Research (LRCX - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.
Applied Materials Inc. (NASDAQ: AMAT) typically has beaten its earnings and sales expectations. Apparently, the top U.S. player for semiconductor capital equipment is finding out that 29% in quarterly revenue growth (to $4.57 billion) and a 54% jump in operating income (to $1.22 per share) from a year ago aren’t enough in the face of expectations ahead.
Chicago, IL – May 18, 2018 – Zacks Equity Research highlights Discovery Communications (DISCA - Free Report) as the Bull of the Day, Taiwan Semiconductor Manufacturing Company (TSM - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onWorld Wrestling Entertainment (WWE - Free Report) and Comcast (CMCSA - Free Report) .
Chicago, IL – May 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Kratos Defense & Security Solutions, Inc. (KTOS - Free Report) , The Boeing Company (BA - Free Report) , Wesco Aircraft Holdings, Inc.
Chicago, IL – May 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Federated National Holding Co. (FNHC - Free Report) , Delta Apparel Inc. (DLA - Free Report) , Turtle Beach Corp. (HEAR - Free Report) , Stoneridge Inc.
21h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
21h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET